BETAHISTINE EG LABO 24 mg, tablet 60 tablets
Active ingredients: Betahistine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETAHISTINE EG LABO 24 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquettes PVC PVDC aluminium de 60 comprimés
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61965574CIP73031874CIP133400930318744Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE BÉTAHISTINEcomprimé | 24 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.